Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Numerous studies postulated the possible modes of anthelmintic activity by targeting alternate or extended regions of colchicine binding domain of helminth β-tubulin. We present three interaction zones (zones vide -1 to -3) in the colchicine binding domain of Haemonchus contortus (a helminth) β-tubulin homology model and developed zone-wise structure-based pharmacophore models coupled with molecular docking technique to unveil the binding hypotheses. The resulted ten structure-based hypotheses were then refined to essential three point pharmacophore features that captured recurring and crucial non-covalent receptor contacts and proposed three characteristics necessary for optimal zone-2 binding: a conserved pair of H bond acceptor (HBA to form H bond with Asn226 residue) and an aliphatic moiety of molecule separated by 3.75±0.44Å. Further, an aliphatic or a heterocyclic group distant (11.75±1.14Å) to the conserved aliphatic site formed the third feature component in the zone-2 specific anthelmintic pharmacophore model. Alternatively, an additional HBA can be substituted as a third component to establish H bonding with Asn204. We discern that selective zone-2 anthelmintics can be designed effectively by closely adapting the pharmacophore feature patterns and its geometrical constraints.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiolchem.2017.02.008DOI Listing

Publication Analysis

Top Keywords

colchicine binding
12
binding domain
12
interaction zones
8
helminth β-tubulin
8
binding
6
exploration interaction
4
zones β-tubulin
4
β-tubulin colchicine
4
domain helminths
4
helminths binding
4

Similar Publications

Molecular Docking and Target-Specific Binding Profiles of Benzosuberane-Based Compounds.

ChemMedChem

September 2025

School of Food Science and Environmental Health, Technological University of Dublin, Grangegorman Lower, Dublin 7, D07 ADY7, Dublin, Ireland.

Cancer, a leading cause of global mortality, is characterized by uncontrolled cell proliferation and remains a significant therapeutic challenge due to drug resistance and treatment failures. Despite advancements in targeted therapies, novel agents are still in strong demand. Benzosuberane, a bicyclic scaffold present in natural products such as colchicine and theaflavin, has emerged as a promising structural core in cancer therapeutics due to its structural flexibility and diverse biological activities, including antitumor, anti-inflammatory, and antimicrobial effects.

View Article and Find Full Text PDF

Background: Coronary heart disease (CHD) is becoming increasingly prevalent worldwide due to the aging population. Although diabetes mellitus (DM) is an independent risk factor for the development of CHD, existing anti-atherosclerotic therapies do not adequately address the mechanism underlying the exacerbation of CHD in diabetic patients. Derived from the Colchicum autumnale plant, colchicine has recently gained recognition as a novel anti-inflammatory agent for CHD.

View Article and Find Full Text PDF

Phytochemical screening, antioxidant, and antimicrobial analysis of Portulaca oleracea seeds with in-silico molecular docking insights.

J Genet Eng Biotechnol

September 2025

Pharmaceutical Chemistry Division, Department of Pharmaceutical Sciences, School of Applied Sciences and Technology, University of Kashmir, Hazratbal, Srinagar 190006 Kashmir, India. Electronic address:

Background: Portulaca oleracea (PO), an annual succulent herb with global distribution, has been used medicinally since ancient times, earning the title "global panacea."

Aim: This study aimed to perform phytochemical screening, antioxidant and antimicrobial analysis of PO seeds, including GCMS analysis of methanolic extract and molecular docking for antimicrobial mechanisms.

Materials And Methods: PO seeds underwent phytochemical screening and methanolic extract analysis via DPPH, NO radical scavenging, and reducing power assays.

View Article and Find Full Text PDF

Microtubules, critical to diverse cellular processes, represent a clinically validated target for anticancer therapeutics. In this study, a virtual screening of the Specs library, consisting of 200,340 compounds, was conducted to target the taxane and colchicine binding sites on tubulin, resulting in the identification of 93 promising candidates for further analysis. Subsequent characterization revealed a nicotinic acid derivative (compound 89) as a potent tubulin inhibitor, demonstrating significant anti-tumor efficacy in vitro and in vivo, with no observable toxicity at therapeutic doses in mice.

View Article and Find Full Text PDF

Discovery of pyrazolo[1,5-a]pyrimidines: Synthesis, in silico insights, and anticancer activity via novel CDK2/Tubulin dual inhibition approach.

Bioorg Chem

August 2025

Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University, Ain Helwan, 11795 Cairo, Egypt; PharmD program, Egypt-Japan University of Science and Technology (E-JUST), New Borg El-Arab City, 21934 Alexandria, Egypt. Electronic address:

A series of new pyrazolo[1,5-a]pyrimidine derivatives was designed and synthesized as dual CDK2/tubulin polymerization inhibitors. MTT cytotoxicity assay was conducted against five cancer cell lines and one normal cell line. Compounds 6h, and 6q displayed the highest antiproliferative activity, with average IC values of 7.

View Article and Find Full Text PDF